|
1
|
Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement.
|
Circulation
|
2005
|
43.74
|
|
2
|
Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity.
|
Circulation
|
2009
|
35.24
|
|
3
|
Markers of inflammation and cardiovascular disease: application to clinical and public health practice: A statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association.
|
Circulation
|
2003
|
23.97
|
|
4
|
Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines.
|
Circulation
|
2004
|
23.07
|
|
5
|
Definition of metabolic syndrome: Report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition.
|
Circulation
|
2004
|
20.67
|
|
6
|
Particulate matter air pollution and cardiovascular disease: An update to the scientific statement from the American Heart Association.
|
Circulation
|
2010
|
19.30
|
|
7
|
ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure): developed in collaboration with the American College of Chest Physicians and the International Society for Heart and Lung Transplantation: endorsed by the Heart Rhythm Society.
|
Circulation
|
2005
|
18.90
|
|
8
|
2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines.
|
J Am Coll Cardiol
|
2013
|
17.18
|
|
9
|
2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines.
|
Circulation
|
2013
|
16.52
|
|
10
|
Scientific evidence underlying the ACC/AHA clinical practice guidelines.
|
JAMA
|
2009
|
13.69
|
|
11
|
ACC/AHA 2005 Practice Guidelines for the management of patients with peripheral arterial disease (lower extremity, renal, mesenteric, and abdominal aortic): a collaborative report from the American Association for Vascular Surgery/Society for Vascular Surgery, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, Society of Interventional Radiology, and the ACC/AHA Task Force on Practice Guidelines (Writing Committee to Develop Guidelines for the Management of Patients With Peripheral Arterial Disease): endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation; National Heart, Lung, and Blood Institute; Society for Vascular Nursing; TransAtlantic Inter-Society Consensus; and Vascular Disease Foundation.
|
Circulation
|
2006
|
13.21
|
|
12
|
Air pollution and cardiovascular disease: a statement for healthcare professionals from the Expert Panel on Population and Prevention Science of the American Heart Association.
|
Circulation
|
2004
|
13.07
|
|
13
|
ACC/AHA/ESC 2006 Guidelines for the Management of Patients with Atrial Fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation): developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society.
|
Circulation
|
2006
|
11.49
|
|
14
|
2013 ACC/AHA guideline on the assessment of cardiovascular risk: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines.
|
Circulation
|
2013
|
10.24
|
|
15
|
ACC/AHA 2007 guidelines for the management of patients with unstable angina/non-ST-Elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines for the Management of Patients With Unstable Angina/Non-ST-Elevation Myocardial Infarction) developed in collaboration with the American College of Emergency Physicians, the Society for Cardiovascular Angiography and Interventions, and the Society of Thoracic Surgeons endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation and the Society for Academic Emergency Medicine.
|
J Am Coll Cardiol
|
2007
|
10.19
|
|
16
|
ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (writing committee to revise the 1998 Guidelines for the Management of Patients With Valvular Heart Disease): developed in collaboration with the Society of Cardiovascular Anesthesiologists: endorsed by the Society for Cardiovascular Angiography and Interventions and the Society of Thoracic Surgeons.
|
Circulation
|
2006
|
9.83
|
|
17
|
AHA Guidelines for Primary Prevention of Cardiovascular Disease and Stroke: 2002 Update: Consensus Panel Guide to Comprehensive Risk Reduction for Adult Patients Without Coronary or Other Atherosclerotic Vascular Diseases. American Heart Association Science Advisory and Coordinating Committee.
|
Circulation
|
2002
|
9.04
|
|
18
|
ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices): developed in collaboration with the American Association for Thoracic Surgery and Society of Thoracic Surgeons.
|
Circulation
|
2008
|
8.94
|
|
19
|
2013 ACC/AHA guideline on the assessment of cardiovascular risk: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines.
|
J Am Coll Cardiol
|
2013
|
8.90
|
|
20
|
Third universal definition of myocardial infarction.
|
J Am Coll Cardiol
|
2012
|
8.59
|
|
21
|
Third universal definition of myocardial infarction.
|
Circulation
|
2012
|
8.47
|
|
22
|
ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (writing Committee to Revise the 1998 guidelines for the management of patients with valvular heart disease) developed in collaboration with the Society of Cardiovascular Anesthesiologists endorsed by the Society for Cardiovascular Angiography and Interventions and the Society of Thoracic Surgeons.
|
J Am Coll Cardiol
|
2006
|
8.36
|
|
23
|
Criteria for evaluation of novel markers of cardiovascular risk: a scientific statement from the American Heart Association.
|
Circulation
|
2009
|
8.11
|
|
24
|
AHA/ACC guidelines for secondary prevention for patients with coronary and other atherosclerotic vascular disease: 2006 update: endorsed by the National Heart, Lung, and Blood Institute.
|
Circulation
|
2006
|
8.01
|
|
25
|
Third universal definition of myocardial infarction.
|
Eur Heart J
|
2012
|
7.98
|
|
26
|
ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction--executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 1999 Guidelines for the Management of Patients With Acute Myocardial Infarction).
|
Circulation
|
2004
|
7.72
|
|
27
|
2010 ACCF/AHA guideline for assessment of cardiovascular risk in asymptomatic adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines.
|
J Am Coll Cardiol
|
2010
|
7.54
|
|
28
|
ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices) developed in collaboration with the American Association for Thoracic Surgery and Society of Thoracic Surgeons.
|
J Am Coll Cardiol
|
2008
|
6.78
|
|
29
|
ACC/AHA 2007 guidelines for the management of patients with unstable angina/non ST-elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines for the Management of Patients With Unstable Angina/Non ST-Elevation Myocardial Infarction): developed in collaboration with the American College of Emergency Physicians, the Society for Cardiovascular Angiography and Interventions, and the Society of Thoracic Surgeons: endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation and the Society for Academic Emergency Medicine.
|
Circulation
|
2007
|
6.78
|
|
30
|
2009 focused updates: ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction (updating the 2004 guideline and 2007 focused update) and ACC/AHA/SCAI guidelines on percutaneous coronary intervention (updating the 2005 guideline and 2007 focused update) a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines.
|
J Am Coll Cardiol
|
2009
|
6.61
|
|
31
|
Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III Guidelines.
|
J Am Coll Cardiol
|
2004
|
6.50
|
|
32
|
ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation--executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation).
|
J Am Coll Cardiol
|
2006
|
6.11
|
|
33
|
ACC/AHA/ESC 2006 Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death: a report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (writing committee to develop Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death): developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society.
|
Circulation
|
2006
|
5.95
|
|
34
|
ACC/AHA/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: a report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Develop Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death).
|
J Am Coll Cardiol
|
2006
|
5.81
|
|
35
|
Association between hospital process performance and outcomes among patients with acute coronary syndromes.
|
JAMA
|
2006
|
5.78
|
|
36
|
ACC/AHA 2005 guidelines for the management of patients with peripheral arterial disease (lower extremity, renal, mesenteric, and abdominal aortic): executive summary a collaborative report from the American Association for Vascular Surgery/Society for Vascular Surgery, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, Society of Interventional Radiology, and the ACC/AHA Task Force on Practice Guidelines (Writing Committee to Develop Guidelines for the Management of Patients With Peripheral Arterial Disease) endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation; National Heart, Lung, and Blood Institute; Society for Vascular Nursing; TransAtlantic Inter-Society Consensus; and Vascular Disease Foundation.
|
J Am Coll Cardiol
|
2006
|
5.70
|
|
37
|
ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction--executive summary. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to revise the 1999 guidelines for the management of patients with acute myocardial infarction).
|
J Am Coll Cardiol
|
2004
|
5.62
|
|
38
|
ACC/AHA 2008 guidelines for the management of adults with congenital heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Develop Guidelines on the Management of Adults With Congenital Heart Disease). Developed in Collaboration With the American Society of Echocardiography, Heart Rhythm Society, International Society for Adult Congenital Heart Disease, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons.
|
J Am Coll Cardiol
|
2008
|
5.57
|
|
39
|
2007 Focused Update of the ACC/AHA 2004 Guidelines for the Management of Patients With ST-Elevation Myocardial Infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines: developed in collaboration With the Canadian Cardiovascular Society endorsed by the American Academy of Family Physicians: 2007 Writing Group to Review New Evidence and Update the ACC/AHA 2004 Guidelines for the Management of Patients With ST-Elevation Myocardial Infarction, Writing on Behalf of the 2004 Writing Committee.
|
Circulation
|
2007
|
5.56
|
|
40
|
Effectiveness-based guidelines for the prevention of cardiovascular disease in women--2011 update: a guideline from the american heart association.
|
Circulation
|
2011
|
5.26
|
|
41
|
Periodontal disease and atherosclerotic vascular disease: does the evidence support an independent association?: a scientific statement from the American Heart Association.
|
Circulation
|
2012
|
5.25
|
|
42
|
2013 AHA/ACC/TOS guideline for the management of overweight and obesity in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and The Obesity Society.
|
Circulation
|
2013
|
5.02
|
|
43
|
β-Blocker use and clinical outcomes in stable outpatients with and without coronary artery disease.
|
JAMA
|
2012
|
4.92
|
|
44
|
ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Revise the 1999 Guidelines for the Management of Patients with Acute Myocardial Infarction).
|
Circulation
|
2004
|
4.88
|
|
45
|
2012 ACCF/AHA/ACP/AATS/PCNA/SCAI/STS Guideline for the diagnosis and management of patients with stable ischemic heart disease: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines, and the American College of Physicians, American Association for Thoracic Surgery, Preventive Cardiovascular Nurses Association, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons.
|
J Am Coll Cardiol
|
2012
|
4.77
|
|
46
|
2009 Focused Updates: ACC/AHA Guidelines for the Management of Patients With ST-Elevation Myocardial Infarction (updating the 2004 Guideline and 2007 Focused Update) and ACC/AHA/SCAI Guidelines on Percutaneous Coronary Intervention (updating the 2005 Guideline and 2007 Focused Update): a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines.
|
Circulation
|
2009
|
4.75
|
|
47
|
Critical issues in peripheral arterial disease detection and management: a call to action.
|
Arch Intern Med
|
2003
|
4.72
|
|
48
|
AHA/ACCF Secondary Prevention and Risk Reduction Therapy for Patients with Coronary and other Atherosclerotic Vascular Disease: 2011 update: a guideline from the American Heart Association and American College of Cardiology Foundation.
|
Circulation
|
2011
|
4.65
|
|
49
|
ACC/AHA 2002 guideline update for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction--summary article: a report of the American College of Cardiology/American Heart Association task force on practice guidelines (Committee on the Management of Patients With Unstable Angina).
|
J Am Coll Cardiol
|
2002
|
4.64
|
|
50
|
ACC/AHA 2002 guideline update for exercise testing: summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Update the 1997 Exercise Testing Guidelines).
|
Circulation
|
2002
|
4.56
|
|
51
|
2010 ACCF/AHA guideline for assessment of cardiovascular risk in asymptomatic adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines.
|
Circulation
|
2010
|
4.56
|
|
52
|
ACC/AHA/NHLBI clinical advisory on the use and safety of statins.
|
J Am Coll Cardiol
|
2002
|
4.50
|
|
53
|
ACC/AHA 2002 guideline update for exercise testing: summary article. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Update the 1997 Exercise Testing Guidelines).
|
J Am Coll Cardiol
|
2002
|
4.48
|
|
54
|
2011 ACCF/AHA/HRS focused updates incorporated into the ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation: a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines.
|
Circulation
|
2011
|
4.48
|
|
55
|
Evidence-based guidelines for cardiovascular disease prevention in women: 2007 update.
|
Circulation
|
2007
|
4.16
|
|
56
|
ACCF/SCCT/ACR/AHA/ASE/ASNC/NASCI/SCAI/SCMR 2010 appropriate use criteria for cardiac computed tomography. A report of the American College of Cardiology Foundation Appropriate Use Criteria Task Force, the Society of Cardiovascular Computed Tomography, the American College of Radiology, the American Heart Association, the American Society of Echocardiography, the American Society of Nuclear Cardiology, the North American Society for Cardiovascular Imaging, the Society for Cardiovascular Angiography and Interventions, and the Society for Cardiovascular Magnetic Resonance.
|
J Am Coll Cardiol
|
2010
|
4.16
|
|
57
|
2007 Focused Update of the ACC/AHA/SCAI 2005 Guideline Update for Percutaneous Coronary Intervention: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines: 2007 Writing Group to Review New Evidence and Update the ACC/AHA/SCAI 2005 Guideline Update for Percutaneous Coronary Intervention, Writing on Behalf of the 2005 Writing Committee.
|
Circulation
|
2007
|
3.92
|
|
58
|
ACC/AHA/NASPE 2002 guideline update for implantation of cardiac pacemakers and antiarrhythmia devices: summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/NASPE Committee to Update the 1998 Pacemaker Guidelines).
|
Circulation
|
2002
|
3.89
|
|
59
|
ACC/AHA guideline update for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction--2002: summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on the Management of Patients With Unstable Angina).
|
Circulation
|
2002
|
3.80
|
|
60
|
2007 focused update of the ACC/AHA 2004 guidelines for the management of patients with ST-elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines.
|
J Am Coll Cardiol
|
2008
|
3.70
|
|
61
|
2013 AHA/ACC guideline on lifestyle management to reduce cardiovascular risk: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines.
|
Circulation
|
2013
|
3.63
|
|
62
|
ACC/AHA Guidelines for the Management of Patients with Peripheral Arterial Disease (lower extremity, renal, mesenteric, and abdominal aortic): a collaborative report from the American Associations for Vascular Surgery/Society for Vascular Surgery, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, Society of Interventional Radiology, and the ACC/AHA Task Force on Practice Guidelines (writing committee to develop guidelines for the management of patients with peripheral arterial disease)--summary of recommendations.
|
J Vasc Interv Radiol
|
2006
|
3.59
|
|
63
|
ACC/AHA/ESC guidelines for the management of patients with supraventricular arrhythmias--executive summary. a report of the American college of cardiology/American heart association task force on practice guidelines and the European society of cardiology committee for practice guidelines (writing committee to develop guidelines for the management of patients with supraventricular arrhythmias) developed in collaboration with NASPE-Heart Rhythm Society.
|
J Am Coll Cardiol
|
2003
|
3.55
|
|
64
|
ACC/AHA 2007 guidelines on perioperative cardiovascular evaluation and care for noncardiac surgery: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines on Perioperative Cardiovascular Evaluation for Noncardiac Surgery): developed in collaboration with the American Society of Echocardiography, American Society of Nuclear Cardiology, Heart Rhythm Society, Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, and Society for Vascular Surgery.
|
Circulation
|
2007
|
3.52
|
|
65
|
ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation: full text: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 guidelines for the management of patients with atrial fibrillation) developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society.
|
Europace
|
2006
|
3.52
|
|
66
|
Definition of metabolic syndrome: report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition.
|
Arterioscler Thromb Vasc Biol
|
2004
|
3.43
|
|
67
|
ACC/AHA/ASE 2003 Guideline Update for the Clinical Application of Echocardiography: summary article. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/ASE Committee to Update the 1997 Guidelines for the Clinical Application of Echocardiography).
|
J Am Soc Echocardiogr
|
2003
|
3.42
|
|
68
|
Evidence-based guidelines for cardiovascular disease prevention in women.
|
Circulation
|
2004
|
3.39
|
|
69
|
Standards for statistical models used for public reporting of health outcomes: an American Heart Association Scientific Statement from the Quality of Care and Outcomes Research Interdisciplinary Writing Group: cosponsored by the Council on Epidemiology and Prevention and the Stroke Council. Endorsed by the American College of Cardiology Foundation.
|
Circulation
|
2005
|
3.38
|
|
70
|
2013 AHA/ACC guideline on lifestyle management to reduce cardiovascular risk: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines.
|
J Am Coll Cardiol
|
2013
|
3.35
|
|
71
|
Clinical management of metabolic syndrome: report of the American Heart Association/National Heart, Lung, and Blood Institute/American Diabetes Association conference on scientific issues related to management.
|
Circulation
|
2004
|
3.35
|
|
72
|
ACC/AHA/NHLBI Clinical Advisory on the Use and Safety of Statins.
|
Circulation
|
2002
|
3.29
|
|
73
|
ACC/AHA 2007 Guidelines on Perioperative Cardiovascular Evaluation and Care for Noncardiac Surgery: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines on Perioperative Cardiovascular Evaluation for Noncardiac Surgery): Developed in Collaboration With the American Society of Echocardiography, American Society of Nuclear Cardiology, Heart Rhythm Society, Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, and Society for Vascular Surgery.
|
Circulation
|
2007
|
3.25
|
|
74
|
ACC/AHA 2002 guideline update for the management of patients with chronic stable angina--summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on the Management of Patients With Chronic Stable Angina).
|
Circulation
|
2003
|
3.16
|
|
75
|
ACC/AHA/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: a report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Develop guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death) developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society.
|
Europace
|
2006
|
3.11
|
|
76
|
International Day for the Evaluation of Abdominal Obesity (IDEA): a study of waist circumference, cardiovascular disease, and diabetes mellitus in 168,000 primary care patients in 63 countries.
|
Circulation
|
2007
|
3.01
|
|
77
|
ACC/AHA/SCAI 2005 guideline update for percutaneous coronary intervention: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/SCAI Writing Committee to Update 2001 Guidelines for Percutaneous Coronary Intervention).
|
Circulation
|
2006
|
2.98
|
|
78
|
ACC/AHA/ASE 2003 guideline update for the clinical application of echocardiography: summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/ASE Committee to Update the 1997 Guidelines for the Clinical Application of Echocardiography).
|
Circulation
|
2003
|
2.97
|
|
79
|
2007 chronic angina focused update of the ACC/AHA 2002 guidelines for the management of patients with chronic stable angina: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines Writing Group to develop the focused update of the 2002 guidelines for the management of patients with chronic stable angina.
|
J Am Coll Cardiol
|
2007
|
2.95
|
|
80
|
Effectiveness-based guidelines for the prevention of cardiovascular disease in women--2011 update: a guideline from the American Heart Association.
|
J Am Coll Cardiol
|
2011
|
2.89
|
|
81
|
The importance of population-wide sodium reduction as a means to prevent cardiovascular disease and stroke: a call to action from the American Heart Association.
|
Circulation
|
2011
|
2.89
|
|
82
|
ACC/AHA/ASNC guidelines for the clinical use of cardiac radionuclide imaging--executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/ASNC Committee to Revise the 1995 Guidelines for the Clinical Use of Cardiac Radionuclide Imaging).
|
J Am Coll Cardiol
|
2003
|
2.88
|
|
83
|
ACC/AHA/ASNC guidelines for the clinical use of cardiac radionuclide imaging--executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/ASNC Committee to Revise the 1995 Guidelines for the Clinical Use of Cardiac Radionuclide Imaging).
|
Circulation
|
2003
|
2.88
|
|
84
|
ACC/AHA 2007 Guidelines on Perioperative Cardiovascular Evaluation and Care for Noncardiac Surgery: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines on Perioperative Cardiovascular Evaluation for Noncardiac Surgery) Developed in Collaboration With the American Society of Echocardiography, American Society of Nuclear Cardiology, Heart Rhythm Society, Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, and Society for Vascular Surgery.
|
J Am Coll Cardiol
|
2007
|
2.77
|
|
85
|
2012 ACCF/AHA/ACP/AATS/PCNA/SCAI/STS guideline for the diagnosis and management of patients with stable ischemic heart disease: a report of the American College of Cardiology Foundation/American Heart Association task force on practice guidelines, and the American College of Physicians, American Association for Thoracic Surgery, Preventive Cardiovascular Nurses Association, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons.
|
Circulation
|
2012
|
2.72
|
|
86
|
2011 ACCF/AHA Focused Update Incorporated Into the ACC/AHA 2007 Guidelines for the Management of Patients With Unstable Angina/Non-ST-Elevation Myocardial Infarction: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines.
|
Circulation
|
2011
|
2.72
|
|
87
|
ACC/AHA/ESC guidelines for the management of patients with supraventricular arrhythmias--executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Develop Guidelines for the Management of Patients With Supraventricular Arrhythmias).
|
Circulation
|
2003
|
2.68
|
|
88
|
2010 ACCF/AHA guideline for assessment of cardiovascular risk in asymptomatic adults: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines.
|
Circulation
|
2010
|
2.58
|
|
89
|
AHA/ACC guidelines for secondary prevention for patients with coronary and other atherosclerotic vascular disease: 2006 update endorsed by the National Heart, Lung, and Blood Institute.
|
J Am Coll Cardiol
|
2006
|
2.57
|
|
90
|
Utilization of early invasive management strategies for high-risk patients with non-ST-segment elevation acute coronary syndromes: results from the CRUSADE Quality Improvement Initiative.
|
JAMA
|
2004
|
2.55
|
|
91
|
ACC/AHA/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death--executive summary: A report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Develop Guidelines for Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death) Developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society.
|
Eur Heart J
|
2006
|
2.54
|
|
92
|
Racial and ethnic differences in the treatment of acute myocardial infarction: findings from the Get With the Guidelines-Coronary Artery Disease program.
|
Circulation
|
2010
|
2.53
|
|
93
|
Living alone and cardiovascular risk in outpatients at risk of or with atherothrombosis.
|
Arch Intern Med
|
2012
|
2.53
|
|
94
|
Metformin use and mortality among patients with diabetes and atherothrombosis.
|
Arch Intern Med
|
2010
|
2.52
|
|
95
|
ACC/AHA guideline update for perioperative cardiovascular evaluation for noncardiac surgery---executive summary a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Update the 1996 Guidelines on Perioperative Cardiovascular Evaluation for Noncardiac Surgery).
|
Circulation
|
2002
|
2.46
|
|
96
|
2007 focused update of the ACC/AHA/SCAI 2005 guideline update for percutaneous coronary intervention: a report of the American College of Cardiology/American Heart Association Task Force on Practice guidelines.
|
J Am Coll Cardiol
|
2008
|
2.46
|
|
97
|
AHA/ACCF secondary prevention and risk reduction therapy for patients with coronary and other atherosclerotic vascular disease: 2011 update: a guideline from the American Heart Association and American College of Cardiology Foundation endorsed by the World Heart Federation and the Preventive Cardiovascular Nurses Association.
|
J Am Coll Cardiol
|
2011
|
2.45
|
|
98
|
Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute scientific statement.
|
Curr Opin Cardiol
|
2006
|
2.41
|
|
99
|
ACC/AHA/SCAI 2005 Guideline Update for Percutaneous Coronary Intervention-Summary Article: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/SCAI Writing Committee to Update the 2001 Guidelines for Percutaneous Coronary Intervention).
|
J Am Coll Cardiol
|
2006
|
2.35
|
|
100
|
Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute scientific statement: Executive Summary.
|
Crit Pathw Cardiol
|
2005
|
2.31
|
|
101
|
Prolonged emergency department stays of non-ST-segment-elevation myocardial infarction patients are associated with worse adherence to the American College of Cardiology/American Heart Association guidelines for management and increased adverse events.
|
Ann Emerg Med
|
2007
|
2.28
|
|
102
|
ACC/AHA 2004 guideline update for coronary artery bypass graft surgery: summary article. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Update the 1999 Guidelines for Coronary Artery Bypass Graft Surgery).
|
J Am Coll Cardiol
|
2004
|
2.27
|
|
103
|
ACC/AHA/SCAI 2005 guideline update for percutaneous coronary intervention: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/SCAI Writing Committee to Update the 2001 Guidelines for Percutaneous Coronary Intervention).
|
J Am Coll Cardiol
|
2006
|
2.16
|
|
104
|
Evolution in cardiovascular care for elderly patients with non-ST-segment elevation acute coronary syndromes: results from the CRUSADE National Quality Improvement Initiative.
|
J Am Coll Cardiol
|
2005
|
2.16
|
|
105
|
ACC/AHA/NASPE 2002 guideline update for implantation of cardiac pacemakers and antiarrhythmia devices: summary article. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/NASPE Committee to Update the 1998 Pacemaker Guidelines).
|
J Cardiovasc Electrophysiol
|
2002
|
2.14
|
|
106
|
ACC/AHA Guideline Update for Perioperative Cardiovascular Evaluation for Noncardiac Surgery--Executive Summary. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Update the 1996 Guidelines on Perioperative Cardiovascular Evaluation for Noncardiac Surgery).
|
Anesth Analg
|
2002
|
2.11
|
|
107
|
ACC/AHA guideline update for perioperative cardiovascular evaluation for noncardiac surgery--executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Update the 1996 Guidelines on Perioperative Cardiovascular Evaluation for Noncardiac Surgery).
|
J Am Coll Cardiol
|
2002
|
2.08
|
|
108
|
Lipid levels in patients hospitalized with coronary artery disease: an analysis of 136,905 hospitalizations in Get With The Guidelines.
|
Am Heart J
|
2008
|
2.06
|
|
109
|
ACC/AHA 2007 guidelines on perioperative cardiovascular evaluation and care for noncardiac surgery: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines on Perioperative Cardiovascular Evaluation for Noncardiac Surgery) developed in collaboration with the American Society of Echocardiography, American Society of Nuclear Cardiology, Heart Rhythm Society, Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, and Society for Vascular Surgery.
|
J Am Coll Cardiol
|
2007
|
2.04
|
|
110
|
World Heart Day 2002: the international burden of cardiovascular disease: responding to the emerging global epidemic.
|
Circulation
|
2002
|
2.02
|
|
111
|
ACC/AHA/SCAI 2005 Guideline Update for Percutaneous Coronary Intervention--summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/SCAI Writing Committee to Update the 2001 Guidelines for Percutaneous Coronary Intervention).
|
Circulation
|
2006
|
2.00
|
|
112
|
Comparative determinants of 4-year cardiovascular event rates in stable outpatients at risk of or with atherothrombosis.
|
JAMA
|
2010
|
1.97
|
|
113
|
Obesity and age of first non-ST-segment elevation myocardial infarction.
|
J Am Coll Cardiol
|
2008
|
1.97
|
|
114
|
Resistant hypertension: a frequent and ominous finding among hypertensive patients with atherothrombosis.
|
Eur Heart J
|
2012
|
1.95
|
|
115
|
ACC/AHA/NHLBI Clinical Advisory on the Use and Safety of Statins.
|
Stroke
|
2002
|
1.93
|
|
116
|
ACC/AHA 2007 guidelines on perioperative cardiovascular evaluation and care for noncardiac surgery: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines on Perioperative Cardiovascular Evaluation for Noncardiac Surgery).
|
Anesth Analg
|
2008
|
1.86
|
|
117
|
Three-year follow-up and event rates in the international REduction of Atherothrombosis for Continued Health Registry.
|
Eur Heart J
|
2009
|
1.84
|
|
118
|
2007 chronic angina focused update of the ACC/AHA 2002 Guidelines for the management of patients with chronic stable angina: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines Writing Group to develop the focused update of the 2002 Guidelines for the management of patients with chronic stable angina.
|
Circulation
|
2007
|
1.84
|
|
119
|
ACC/AHA 2004 guideline update for coronary artery bypass graft surgery: summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Update the 1999 Guidelines for Coronary Artery Bypass Graft Surgery).
|
Circulation
|
2004
|
1.81
|
|
120
|
Racial variations in treatment and outcomes of black and white patients with high-risk non-ST-elevation acute coronary syndromes: insights from CRUSADE (Can Rapid Risk Stratification of Unstable Angina Patients Suppress Adverse Outcomes With Early Implementation of the ACC/AHA Guidelines?).
|
Circulation
|
2005
|
1.79
|
|
121
|
ACC/AHA 2008 guideline update on valvular heart disease: focused update on infective endocarditis: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines: endorsed by the Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons.
|
Circulation
|
2008
|
1.71
|
|
122
|
Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines.
|
Arterioscler Thromb Vasc Biol
|
2004
|
1.70
|
|
123
|
Evidence-based guidelines for cardiovascular disease prevention in women: 2007 update.
|
J Am Coll Cardiol
|
2007
|
1.69
|
|
124
|
Discovering the full spectrum of cardiovascular disease: Minority Health Summit 2003: report of the Obesity, Metabolic Syndrome, and Hypertension Writing Group.
|
Circulation
|
2005
|
1.67
|
|
125
|
Acute clopidogrel use and outcomes in patients with non-ST-segment elevation acute coronary syndromes undergoing coronary artery bypass surgery.
|
J Am Coll Cardiol
|
2006
|
1.67
|
|
126
|
Recent trends in the care of patients with non-ST-segment elevation acute coronary syndromes: insights from the CRUSADE initiative.
|
Arch Intern Med
|
2006
|
1.66
|
|
127
|
Insurance coverage and care of patients with non-ST-segment elevation acute coronary syndromes.
|
Ann Intern Med
|
2006
|
1.62
|
|
128
|
Clopidogrel to treat patients with non-ST-segment elevation acute coronary syndromes after hospital discharge.
|
Arch Intern Med
|
2006
|
1.61
|
|
129
|
Evidence-based guidelines for cardiovascular disease prevention in women.
|
J Am Coll Cardiol
|
2004
|
1.59
|
|
130
|
Influence of inpatient service specialty on care processes and outcomes for patients with non ST-segment elevation acute coronary syndromes.
|
Circulation
|
2007
|
1.59
|
|
131
|
2012 ACCF/AHA/ACP/AATS/PCNA/SCAI/STS guideline for the diagnosis and management of patients with stable ischemic heart disease: executive summary: a report of the American College of Cardiology Foundation/American Heart Association task force on practice guidelines, and the American College of Physicians, American Association for Thoracic Surgery, Preventive Cardiovascular Nurses Association, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons.
|
Circulation
|
2012
|
1.54
|
|
132
|
Evidence-based guidelines for cardiovascular disease prevention in women. American Heart Association scientific statement.
|
Arterioscler Thromb Vasc Biol
|
2004
|
1.49
|
|
133
|
Relationship between procedure indications and outcomes of percutaneous coronary interventions by American College of Cardiology/American Heart Association Task Force Guidelines.
|
Circulation
|
2005
|
1.47
|
|
134
|
ACCF/AHA consensus conference report on professionalism and ethics.
|
Circulation
|
2004
|
1.47
|
|
135
|
Treatment of blood cholesterol to reduce atherosclerotic cardiovascular disease risk in adults: synopsis of the 2013 American College of Cardiology/American Heart Association cholesterol guideline.
|
Ann Intern Med
|
2014
|
1.47
|
|
136
|
CDC/AHA Workshop on Markers of Inflammation and Cardiovascular Disease: Application to Clinical and Public Health Practice: overview.
|
Circulation
|
2004
|
1.44
|
|
137
|
Recommendation to develop strategies to increase the number of ST-segment-elevation myocardial infarction patients with timely access to primary percutaneous coronary intervention.
|
Circulation
|
2006
|
1.39
|
|
138
|
Improving quality of care through disease management: principles and recommendations from the American Heart Association's Expert Panel on Disease Management.
|
Circulation
|
2004
|
1.39
|
|
139
|
Clinical management of metabolic syndrome: report of the American Heart Association/National Heart, Lung, and Blood Institute/American Diabetes Association conference on scientific issues related to management.
|
Arterioscler Thromb Vasc Biol
|
2004
|
1.38
|
|
140
|
Improving the care of patients with non-ST-elevation acute coronary syndromes in the emergency department: the CRUSADE initiative.
|
Acad Emerg Med
|
2002
|
1.37
|
|
141
|
Ten-year risk of cardiovascular incidence related to diabetes, prediabetes, and the metabolic syndrome.
|
Am Heart J
|
2007
|
1.36
|
|
142
|
Recommendations for improving the quality of care through stroke centers and systems: an examination of stroke center identification options: multidisciplinary consensus recommendations from the Advisory Working Group on Stroke Center Identification Options of the American Stroke Association.
|
Stroke
|
2002
|
1.32
|
|
143
|
Inclusion of stroke in cardiovascular risk prediction instruments: a statement for healthcare professionals from the American Heart Association/American Stroke Association.
|
Stroke
|
2012
|
1.28
|
|
144
|
Integrating quality into the cycle of therapeutic development.
|
J Am Coll Cardiol
|
2002
|
1.27
|
|
145
|
The obesity paradox in non-ST-segment elevation acute coronary syndromes: results from the Can Rapid risk stratification of Unstable angina patients Suppress ADverse outcomes with Early implementation of the American College of Cardiology/American Heart Association Guidelines Quality Improvement Initiative.
|
Am Heart J
|
2006
|
1.26
|
|
146
|
CDC/AHA Workshop on Markers of Inflammation and Cardiovascular Disease: Application to Clinical and Public Health Practice: report from the clinical practice discussion group.
|
Circulation
|
2004
|
1.25
|
|
147
|
Standards for measures used for public reporting of efficiency in health care: a scientific statement from the American Heart Association Interdisciplinary Council on Quality of Care and Outcomes Research and the American College of Cardiology Foundation.
|
Circulation
|
2008
|
1.25
|
|
148
|
Clinical evaluation of cardiovascular devices: principles, problems, and proposals for European regulatory reform. Report of a policy conference of the European Society of Cardiology.
|
Eur Heart J
|
2011
|
1.25
|
|
149
|
Atherosclerotic Vascular Disease Conference: Executive summary: Atherosclerotic Vascular Disease Conference proceeding for healthcare professionals from a special writing group of the American Heart Association.
|
Circulation
|
2004
|
1.24
|
|
150
|
2016 ACC Expert Consensus Decision Pathway on the Role of Non-Statin Therapies for LDL-Cholesterol Lowering in the Management of Atherosclerotic Cardiovascular Disease Risk: A Report of the American College of Cardiology Task Force on Clinical Expert Consensus Documents.
|
J Am Coll Cardiol
|
2016
|
1.24
|
|
151
|
Prevention Conference VII: Obesity, a worldwide epidemic related to heart disease and stroke: Group III: worldwide comorbidities of obesity.
|
Circulation
|
2004
|
1.23
|
|
152
|
Cardiovascular manpower: the looming crisis.
|
Circulation
|
2004
|
1.23
|
|
153
|
Documented traditional cardiovascular risk factors and mortality in non-ST-segment elevation myocardial infarction.
|
Am Heart J
|
2007
|
1.21
|
|
154
|
Improved treatment of hospitalized coronary artery disease patients with the get with the guidelines program.
|
Crit Pathw Cardiol
|
2007
|
1.18
|
|
155
|
The influence of risk status on guideline adherence for patients with non-ST-segment elevation acute coronary syndromes.
|
Am Heart J
|
2006
|
1.17
|
|
156
|
ACC/AHA guidelines for the evaluation and management of chronic heart failure in the adult: executive summary.
|
J Heart Lung Transplant
|
2002
|
1.16
|
|
157
|
ACC/AHA 2006 guideline update on perioperative cardiovascular evaluation for noncardiac surgery: focused update on perioperative beta-blocker therapy: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2002 Guidelines on Perioperative Cardiovascular Evaluation for Noncardiac Surgery) developed in collaboration with the American Society of Echocardiography, American Society of Nuclear Cardiology, Heart Rhythm Society, Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, and Society for Vascular Medicine and Biology.
|
J Am Coll Cardiol
|
2006
|
1.14
|
|
158
|
[ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation--excutive summary].
|
Rev Port Cardiol
|
2007
|
1.10
|
|
159
|
ACC/AHA 2006 guideline update on perioperative cardiovascular evaluation for noncardiac surgery: focused update on perioperative beta-blocker therapy: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2002 Guidelines on Perioperative Cardiovascular Evaluation for Noncardiac Surgery): developed in collaboration with the American Society of Echocardiography, American Society of Nuclear Cardiology, Heart Rhythm Society, Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, and Society for Vascular Medicine and Biology.
|
Circulation
|
2006
|
1.09
|
|
160
|
Getting guidelines correct: their evidence-based recommendations for use of nonstatins added to statins and the need for follow-up lipid testing.
|
J Am Coll Cardiol
|
2015
|
1.09
|
|
161
|
Task force #1--magnitude of the prevention problem: opportunities and challenges. 33rd Bethesda Conference.
|
J Am Coll Cardiol
|
2002
|
1.09
|
|
162
|
2016 ACC/AHA Guideline Focused Update on Duration of Dual Antiplatelet Therapy in Patients With Coronary Artery Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines.
|
J Am Coll Cardiol
|
2016
|
1.08
|
|
163
|
Attained educational level and incident atherothrombotic events in low- and middle-income compared with high-income countries.
|
Circulation
|
2010
|
1.08
|
|
164
|
Identifying patients at high risk of a cardiovascular event in the near future: current status and future directions: report of a national heart, lung, and blood institute working group.
|
Circulation
|
2010
|
1.07
|
|
165
|
Lipid-lowering intensification and low-density lipoprotein cholesterol achievement from hospital admission to 1-year follow-up after an acute coronary syndrome event: results from the Medications ApplIed aNd SusTAINed Over Time (MAINTAIN) registry.
|
Am Heart J
|
2010
|
1.07
|
|
166
|
Frequency and consequences of recording an electrocardiogram >10 minutes after arrival in an emergency room in non-ST-segment elevation acute coronary syndromes (from the CRUSADE Initiative).
|
Am J Cardiol
|
2005
|
1.07
|
|
167
|
Adherence to secondary prevention medications and four-year outcomes in outpatients with atherosclerosis.
|
Am J Med
|
2013
|
1.06
|
|
168
|
Stroke: working toward a prioritized world agenda.
|
Stroke
|
2010
|
1.05
|
|
169
|
Mast cell tryptase: a new biomarker in patients with stable coronary artery disease.
|
Atherosclerosis
|
2005
|
1.05
|
|
170
|
Left ventricular end-diastolic pressure and risk of subsequent heart failure in patients following an acute myocardial infarction.
|
Congest Heart Fail
|
2007
|
1.04
|
|
171
|
The paradoxical use of cardiac catheterization in patients with non-ST-elevation acute coronary syndromes: lessons from the Can Rapid Stratification of Unstable Angina Patients Suppress Adverse Outcomes With Early Implementation of the ACC /AHA Guidelines (CRUSADE) Quality Improvement Initiative.
|
Am Heart J
|
2009
|
1.04
|
|
172
|
2011 ASA/ACCF/AHA/AANN/AANS/ACR/ASNR/CNS/SAIP/SCAI/SIR/SNIS/SVM/SVS guideline on the management of patients with extracranial carotid and vertebral artery disease: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines, and the American Stroke Association, American Association of Neuroscience Nurses, American Association of Neurological Surgeons, American College of Radiology, American Society of Neuroradiology, Congress of Neurological Surgeons, Society of Atherosclerosis Imaging and Prevention, Society for Cardiovascular Angiography and Interventions, Society of Interventional Radiology, Society of NeuroInterventional Surgery, Society for Vascular Medicine, and Society for Vascular Surgery. Developed in collaboration with the American Academy of Neurology and Society of Cardiovascular Computed Tomography.
|
Catheter Cardiovasc Interv
|
2011
|
1.04
|
|
173
|
Discharge antithrombotic strategies among patients with acute coronary syndrome previously on warfarin anticoagulation: physician practice in the CRUSADE registry.
|
Am Heart J
|
2007
|
1.04
|
|
174
|
Prior polyvascular disease: risk factor for adverse ischaemic outcomes in acute coronary syndromes.
|
Eur Heart J
|
2009
|
1.04
|
|
175
|
Temporal trends in the use of early cardiac catheterization in patients with non-ST-segment elevation acute coronary syndromes (results from CRUSADE).
|
Am J Cardiol
|
2006
|
1.03
|
|
176
|
Low priority of cardiovascular and chronic diseases on the global health agenda: a cause for concern.
|
Circulation
|
2007
|
1.02
|
|
177
|
Regional outcomes after admission for high-risk non-ST-segment elevation acute coronary syndromes.
|
Am J Med
|
2006
|
1.02
|
|
178
|
A 20-year experience with urgent percutaneous cardiopulmonary bypass for salvage of potential survivors of refractory cardiovascular collapse.
|
J Thorac Cardiovasc Surg
|
2010
|
1.02
|
|
179
|
An international model to predict recurrent cardiovascular disease.
|
Am J Med
|
2012
|
1.02
|
|
180
|
Prevention Conference VI: Diabetes and Cardiovascular Disease: Writing Group VI: revascularization in diabetic patients.
|
Circulation
|
2002
|
1.01
|
|
181
|
Stroke: working toward a prioritized world agenda.
|
Cerebrovasc Dis
|
2010
|
1.01
|
|
182
|
Atherosclerotic Vascular Disease Conference: Writing Group II: risk factors.
|
Circulation
|
2004
|
1.00
|
|
183
|
Atherosclerotic Peripheral Vascular Disease Symposium II: nomenclature for vascular diseases.
|
Circulation
|
2008
|
1.00
|
|
184
|
Contemporary awareness and understanding of cholesterol as a risk factor: results of an American Heart Association national survey.
|
Arch Intern Med
|
2003
|
1.00
|
|
185
|
Ethnic differences in cardiovascular risks and mortality in atherothrombotic disease: insights from the Reduction of Atherothrombosis for Continued Health (REACH) registry.
|
Mayo Clin Proc
|
2011
|
1.00
|
|
186
|
Our time: a call to save preventable death from cardiovascular disease (heart disease and stroke).
|
J Am Coll Cardiol
|
2012
|
0.99
|
|
187
|
Risk-adjusted mortality analysis of percutaneous coronary interventions by American College of Cardiology/American Heart Association guidelines recommendations.
|
Am J Cardiol
|
2006
|
0.99
|
|
188
|
Frequency, predictors, and outcomes of drug-eluting stent utilization in patients with high-risk non-ST-segment elevation acute coronary syndromes.
|
Am J Cardiol
|
2005
|
0.98
|
|
189
|
Clinical characteristics, process of care, and outcomes of Hispanic patients presenting with non-ST-segment elevation acute coronary syndromes: results from Can Rapid risk stratification of Unstable angina patients Suppress ADverse outcomes with Early implementation of the ACC/AHA Guidelines (CRUSADE).
|
Am Heart J
|
2006
|
0.97
|
|
190
|
Care of non-ST-segment elevation patients: insights from the CRUSADE national quality improvement initiative.
|
Am Heart J
|
2004
|
0.97
|
|
191
|
34th Bethesda Conference: Task force #4--How do we select patients for atherosclerosis imaging?
|
J Am Coll Cardiol
|
2003
|
0.97
|
|
192
|
Translating research into practice for healthcare providers: the American Heart Association's strategy for building healthier lives, free of cardiovascular diseases and stroke.
|
Circulation
|
2008
|
0.97
|
|
193
|
The association between socioeconomic status of high-risk patients with coronary heart disease and the treatment rates of evidence-based medicine for coronary heart disease secondary prevention in China: Results from the Bridging the Gap on CHD Secondary Prevention in China (BRIG) Project.
|
Am Heart J
|
2009
|
0.96
|
|
194
|
2009 focused updates: ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction (updating the 2004 guideline and 2007 focused update) and ACC/AHA/SCAI guidelines on percutaneous coronary intervention (updating the 2005 guideline and 2007 focused update): a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines.
|
Catheter Cardiovasc Interv
|
2009
|
0.96
|
|
195
|
Changes in patterns of coronary revascularization strategies for patients with acute coronary syndromes (from the CRUSADE Quality Improvement Initiative).
|
Am J Cardiol
|
2007
|
0.96
|
|
196
|
Ethnic-specific criteria for the metabolic syndrome: evidence from China.
|
Diabetes Care
|
2006
|
0.96
|
|
197
|
Comparison of baseline characteristics, treatment patterns, and in-hospital outcomes of Asian versus non-Asian white Americans with non-ST-segment elevation acute coronary syndromes from the CRUSADE quality improvement initiative.
|
Am J Cardiol
|
2007
|
0.94
|
|
198
|
American College of Cardiology/American Heart Association clinical practice guidelines: Part II: evolutionary changes in a continuous quality improvement project.
|
Circulation
|
2003
|
0.94
|
|
199
|
A summary of implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines.
|
Arterioscler Thromb Vasc Biol
|
2004
|
0.94
|
|
200
|
Patterns of transfer for patients with non-ST-segment elevation acute coronary syndrome from community to tertiary care hospitals.
|
Am Heart J
|
2008
|
0.93
|
|
201
|
Reducing the global burden of ischemic heart disease and stroke: a challenge for the cardiovascular community and the United Nations.
|
Circulation
|
2011
|
0.91
|
|
202
|
Acute ST-elevation myocardial infarction in patients hospitalized for noncardiac conditions.
|
J Am Heart Assoc
|
2013
|
0.91
|
|
203
|
ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction--executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 1999 Guidelines for the Management of Patients With Acute Myocardial Infarction).
|
Can J Cardiol
|
2004
|
0.91
|
|
204
|
Predictors of long-term adherence to evidence-based cardiovascular disease medications in outpatients with stable atherothrombotic disease: findings from the REACH Registry.
|
Clin Cardiol
|
2013
|
0.90
|
|
205
|
2016 ACC/AHA guideline focused update on duration of dual antiplatelet therapy in patients with coronary artery disease: A report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines.
|
J Thorac Cardiovasc Surg
|
2016
|
0.89
|
|
206
|
ACC/AHA/SCAI 2005 guideline update for percutaneous coronary intervention--summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/SCAI Writing Committee to update the 2001 Guidelines for Percutaneous Coronary Intervention).
|
Catheter Cardiovasc Interv
|
2006
|
0.89
|
|
207
|
ACCF/AHA clinical practice guideline methodology summit report: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines.
|
J Am Coll Cardiol
|
2012
|
0.89
|
|
208
|
beta-Blocker use following myocardial infarction: low prevalence of evidence-based dosing.
|
Am Heart J
|
2010
|
0.89
|
|
209
|
Standards for measures used for public reporting of efficiency in health care: a scientific statement from the American Heart Association Interdisciplinary Council on Quality of Care and Outcomes research and the American College of Cardiology Foundation.
|
J Am Coll Cardiol
|
2008
|
0.88
|
|
210
|
Lipid management in patients with unstable angina pectoris and non-ST-segment elevation acute myocardial infarction (from CRUSADE).
|
Am J Cardiol
|
2005
|
0.88
|
|
211
|
Ethnic differences in the prevalence and treatment of cardiovascular risk factors in US outpatients with peripheral arterial disease: insights from the reduction of atherothrombosis for continued health (REACH) registry.
|
Am Heart J
|
2009
|
0.88
|
|
212
|
Management of hyperlipidemia in older adults.
|
J Cardiovasc Pharmacol Ther
|
2009
|
0.87
|
|
213
|
The Heart of 25 by 25: Achieving the Goal of Reducing Global and Regional Premature Deaths From Cardiovascular Diseases and Stroke: A Modeling Study From the American Heart Association and World Heart Federation.
|
Circulation
|
2016
|
0.87
|
|
214
|
Periodontal disease in patients with acute myocardial infarction: prevalence and contribution to elevated C-reactive protein levels.
|
Am Heart J
|
2004
|
0.86
|
|
215
|
High-density lipoprotein subclasses are a potential intermediary between alcohol intake and reduced risk of cardiovascular disease: the Rancho Bernardo Study.
|
Br J Nutr
|
2010
|
0.85
|
|
216
|
ACC/AHA 2008 statement on performance measurement and reperfusion therapy: a report of the ACC/AHA Task Force on Performance Measures (Work Group to address the challenges of performance measurement and reperfusion therapy).
|
Circulation
|
2008
|
0.85
|
|
217
|
Predictors of quality of life among women with coronary heart disease.
|
Qual Life Res
|
2006
|
0.85
|
|
218
|
Has guideline development gone astray? No.
|
BMJ
|
2010
|
0.85
|
|
219
|
Risk factors and outcomes for patients with vascular disease and serious bleeding events.
|
Heart
|
2011
|
0.84
|
|
220
|
Stroke: working toward a prioritized world agenda.
|
Int J Stroke
|
2010
|
0.84
|
|
221
|
Changing the model of care for patients with acute coronary syndromes.
|
Am Heart J
|
2003
|
0.84
|
|
222
|
Moving from political declaration to action on reducing the global burden of cardiovascular diseases: a statement from the Global Cardiovascular Disease Taskforce.
|
J Am Coll Cardiol
|
2013
|
0.83
|
|
223
|
The impending cardiovascular pandemic in China.
|
Circ Cardiovasc Qual Outcomes
|
2010
|
0.83
|
|
224
|
Global variation in the prevalence of elevated cholesterol in outpatients with established vascular disease or 3 cardiovascular risk factors according to national indices of economic development and health system performance.
|
Circulation
|
2012
|
0.83
|
|
225
|
Improving quality of care through disease management: principles and recommendations from the American Heart Association's Expert Panel on Disease Management.
|
Stroke
|
2004
|
0.83
|
|
226
|
Development of systems of care for ST-elevation myocardial infarction patients: the patient and public perspective.
|
Circulation
|
2007
|
0.82
|
|
227
|
Late outcomes after carotid artery stenting versus carotid endarterectomy: insights from a propensity-matched analysis of the Reduction of Atherothrombosis for Continued Health (REACH) Registry.
|
Circulation
|
2010
|
0.82
|
|
228
|
Brazilian Society of Cardiology: letter from Rio de Janeiro - III Brazil Prevent / I Latin American Prevent.
|
Arq Bras Cardiol
|
2013
|
0.82
|
|
229
|
The lady aspirin for cardiovascular disease.
|
Lancet
|
2005
|
0.81
|
|
230
|
A randomized clinical trial of secondary prevention among women hospitalized with coronary heart disease.
|
J Womens Health (Larchmt)
|
2010
|
0.81
|
|
231
|
Summary of the American Heart Association's evidence-based guidelines for cardiovascular disease prevention in women.
|
Arterioscler Thromb Vasc Biol
|
2004
|
0.81
|
|
232
|
Commentary: International collaboration needed on device clinical standards.
|
BMJ
|
2011
|
0.81
|
|
233
|
Thiazolidinedione use is not associated with worse cardiovascular outcomes: a study in 28,332 high risk patients with diabetes in routine clinical practice: brief title: thiazolidinedione use and mortality.
|
Int J Cardiol
|
2012
|
0.81
|
|
234
|
ACC/AHA 2008 statement on Performance Measurement and Reperfusion Therapy: a report of the ACC/AHA Task Force on Performance Measures (Work Group to address the challenges of Performance Measurement and Reperfusion Therapy).
|
J Am Coll Cardiol
|
2008
|
0.81
|
|
235
|
ACC/AHA/SCAI/AMA-Convened PCPI/NCQA 2013 Performance Measures for Adults Undergoing Percutaneous Coronary Intervention: A Report of the American College of Cardiology/American Heart Association Task Force on Performance Measures, the Society for Cardiovascular Angiography and Interventions, the American Medical Association-Convened Physician Consortium for Performance Improvement, and the National Committee for Quality Assurance.
|
Circulation
|
2013
|
0.81
|
|
236
|
Efficacy of drug therapy in the secondary prevention of cardiovascular disease and stroke.
|
Am J Cardiol
|
2007
|
0.80
|
|
237
|
ACC/AHA/SCAI/AMA-Convened PCPI/NCQA 2013 performance measures for adults undergoing percutaneous coronary intervention: a report of the American College of Cardiology/American Heart Association Task Force on Performance Measures, the Society for Cardiovascular Angiography and Interventions, the American Medical Association-Convened Physician Consortium for Performance Improvement, and the National Committee for Quality Assurance.
|
J Am Coll Cardiol
|
2013
|
0.79
|
|
238
|
Patterns and prognostic implications of low high-density lipoprotein levels in patients with non-ST-segment elevation acute coronary syndromes.
|
Eur Heart J
|
2008
|
0.79
|
|
239
|
Late medical versus interventional therapy for stable ST-segment elevation myocardial infarction.
|
Nat Clin Pract Cardiovasc Med
|
2008
|
0.79
|
|
240
|
[Prevalence, awareness, and treatment of hypercholesterolemia among inpatients with acute coronary syndrome in China].
|
Zhonghua Xin Xue Guan Bing Za Zhi
|
2009
|
0.78
|
|
241
|
What aspects of hospital culture influence quality?
|
Crit Pathw Cardiol
|
2007
|
0.78
|
|
242
|
Can the Dutch Government really be abandoning smokers to their fate?
|
Lancet
|
2011
|
0.78
|
|
243
|
Psychosocial factors predict coronary heart disease, but what predicts psychosocial risk in women.
|
J Am Med Womens Assoc
|
2003
|
0.77
|
|
244
|
Moving from political declaration to action on reducing the global burden of cardiovascular diseases: a statement from the global cardiovascular disease taskforce.
|
Circulation
|
2013
|
0.77
|
|
245
|
ACC/AHA 2008 guideline update on valvular heart disease: focused update on infective endocarditis: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines endorsed by the Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons.
|
Catheter Cardiovasc Interv
|
2008
|
0.77
|
|
246
|
Measuring and treating serum lipids in patients in a chest pain observation unit.
|
Am J Cardiol
|
2007
|
0.77
|
|
247
|
ACCF/AHA clinical practice guideline methodology summit report: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines.
|
Circulation
|
2012
|
0.77
|
|
248
|
Outcomes of volume-overloaded cardiovascular patients treated with ultrafiltration.
|
J Card Fail
|
2008
|
0.77
|
|
249
|
ACC/AHA Special Report: Clinical Practice Guideline Implementation Strategies: A Summary of Systematic Reviews by the NHLBI Implementation Science Work Group: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines.
|
J Am Coll Cardiol
|
2017
|
0.76
|
|
250
|
Moving from political declaration to action on reducing the global burden of cardiovascular diseases: a statement from the Global Cardiovascular Disease Taskforce.
|
Eur Heart J
|
2013
|
0.76
|
|
251
|
Low-molecular-weight heparin compared with unfractionated heparin for patients with non-ST-segment elevation acute coronary syndromes treated with glycoprotein IIb/IIIa inhibitors: results from the CRUSADE initiative.
|
J Thromb Thrombolysis
|
2006
|
0.76
|
|
252
|
Risk factors for myocardial infarction in Latin America: sobrepeso y obesidad.
|
Circulation
|
2007
|
0.75
|
|
253
|
Long-Term Use of Ticagrelor in Patients with Prior Myocardial Infarction.
|
N Engl J Med
|
2015
|
0.75
|
|
254
|
Can preventive therapy alter the initial presentation of coronary heart disease?
|
Ann Intern Med
|
2006
|
0.75
|
|
255
|
All opinions are not equal.
|
Circulation
|
2004
|
0.75
|
|
256
|
Evidence-based medicine: making the grade: miles to go before we sleep.
|
Circulation
|
2006
|
0.75
|
|
257
|
Reply: Statin dose based on limited evidence.
|
J Am Coll Cardiol
|
2015
|
0.75
|
|
258
|
NCD Alliance responds to Iona Heath.
|
BMJ
|
2011
|
0.75
|
|
259
|
Ethics and professionalism: can there be consensus? An editorial comment on the report of the ACCF/AHA Consensus Conference on Professionalism and Ethics.
|
Circulation
|
2004
|
0.75
|
|
260
|
Task force 6: Code of conduct for staff and volunteer leadership.
|
J Am Coll Cardiol
|
2004
|
0.75
|
|
261
|
Updated guidelines for percutaneous coronary intervention: what are the most important changes?
|
Pol Arch Med Wewn
|
2008
|
0.75
|
|
262
|
COCATS 4 Task Force 2: Training in Preventive Cardiovascular Medicine.
|
J Am Coll Cardiol
|
2015
|
0.75
|
|
263
|
Statements from participating organizations.
|
J Cardiovasc Nurs
|
2011
|
0.75
|
|
264
|
Introduction. Quality of health care.
|
Am Heart J
|
2004
|
0.75
|
|
265
|
Task force 4: Appropriate clinical care and issues of "self-referral".
|
J Am Coll Cardiol
|
2004
|
0.75
|
|
266
|
The Heart of 25 by 25: Achieving the Goal of Reducing Global and Regional Premature Deaths From Cardiovascular Diseases and Stroke: A Modeling Study From the American Heart Association and World Heart Federation.
|
Glob Heart
|
2016
|
0.75
|
|
267
|
Overcoming the challenges facing quality-improvement strategies for non-ST-segment elevation acute coronary syndromes.
|
Am Fam Physician
|
2004
|
0.75
|
|
268
|
Cardiovascular professionalism and ethics in the modern era.
|
J Am Coll Cardiol
|
2004
|
0.75
|
|
269
|
Current European guidelines on cardiovascular disease prevention in clinical practice: an American perspective.
|
Pol Arch Med Wewn
|
2008
|
0.75
|
|
270
|
Influence of timing of troponin elevation on clinical outcomes and use of evidence-based therapies for patients with non-ST-segment elevation acute coronary syndromes.
|
Ann Emerg Med
|
2005
|
0.75
|
|
271
|
President's page: The trust imperative: ethical choice always puts patient first.
|
J Am Coll Cardiol
|
2004
|
0.75
|
|
272
|
Influence of platelet reactivity on BARC classification in East Asian patients undergoing percutaneous coronary intervention. Results of the ACCEL-BLEED study.
|
Thromb Haemost
|
2016
|
0.75
|
|
273
|
Highlights of the 2006 scientific sessions of the European Society of Cardiology: Barcelona, Spain, September 2-5, 2006.
|
J Am Coll Cardiol
|
2006
|
0.75
|
|
274
|
Sustainable Development Goals and the future of cardiovascular health. A statement from the Global Cardiovascular Disease Taskforce.
|
Eur Heart J
|
2014
|
0.75
|
|
275
|
2017 Focused Update of the 2016 ACC Expert Consensus Decision Pathway on the Role of Non-Statin Therapies for LDL-Cholesterol Lowering in the Management of Atherosclerotic Cardiovascular Disease Risk: A Report of the American College of Cardiology Task Force on Expert Consensus Decision Pathways.
|
J Am Coll Cardiol
|
2017
|
0.75
|
|
276
|
Putting prevention into daily practice.
|
Cardiol Clin
|
2003
|
0.75
|
|
277
|
[The present status of the use of aspirin for secondary prevention of coronary artery disease].
|
Zhonghua Nei Ke Za Zhi
|
2009
|
0.75
|
|
278
|
Meditation and Cardiovascular Risk Reduction: A Scientific Statement From the American Heart Association.
|
J Am Heart Assoc
|
2017
|
0.75
|
|
279
|
Cardiologists urged to reduce inappropriate radiation exposure.
|
Eur Heart J
|
2013
|
0.75
|